AnaptysBio Inc (NASDAQ:ANAB) has a beta value of -0.12 and has seen 1.04 million shares traded in the last trading session. The company, currently valued
During the last session, AnaptysBio Inc (NASDAQ:ANAB)’s traded shares were 4.1 million, with the beta value of the company hitting -0.12. At the end of
In today’s recent session, 1.27 million shares of the AnaptysBio Inc (NASDAQ:ANAB) have been traded, and its beta is -0.12. Most recently the company’s share
AnaptysBio Inc (NASDAQ:ANAB)’s traded shares stood at 0.66 million during the last session, with the company’s beta value hitting -0.13. At the close of trading,
In last trading session, AnaptysBio Inc (NASDAQ:ANAB) saw 0.42 million shares changing hands with its beta currently measuring -0.15. Company’s recent per share price level
During the last session, AnaptysBio Inc (NASDAQ:ANAB)’s traded shares were 3.24 million, with the beta value of the company hitting -0.29. At the end of
In today’s recent session, 1.22 million shares of the AnaptysBio Inc (NASDAQ:ANAB) have been traded, and its beta is -0.29. Most recently the company’s share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
